pilot trial
-
Spine
Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization
January 26, 2023 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces…
Read More » -
Spine
InVivo Therapeutics Reports Significant Improvement of First Patient Implanted with Neuro-Spinal Scaffold™
CAMBRIDGE, Mass., Oct 23, 2015 (BUSINESS WIRE) — InVivo Therapeutics Holdings Corp. (NVIV) today announced a 12-month post-implant update for the first…
Read More » -
Spine
InVivo Therapeutics Announces Enrollment of Fourth Patient in Pilot Spinal Cord Injury Trial
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that a fourth patient has been enrolled in the company’s ongoing pilot…
Read More » -
Recon
InVivo Therapeutics Reports Update of First Two Spinal Cord Injury Patients Implanted with Neuro-Spinal Scaffold
CAMBRIDGE, Mass., May 14, 2015 (BUSINESS WIRE) — InVivo Therapeutics Holdings Corp. (NVIV) today announced a six-month post-implant update for the…
Read More »